Pregled bibliografske jedinice broj: 30748
Detection of minimal residual disease in acute promyelocytic leukemia by polymerase chain reaction assay for PML/RARalpha (retinoic acid receptor-alpha) fusion transcript.
Detection of minimal residual disease in acute promyelocytic leukemia by polymerase chain reaction assay for PML/RARalpha (retinoic acid receptor-alpha) fusion transcript. // Molecular Oncology Today / Osmak, Maja ; Škrk, Janez (ur.).
Zagreb: Croatian Ligue Against Cancer, 1996. str. 149-153 (pozvano predavanje, međunarodna recenzija, cjeloviti rad (in extenso), znanstveni)
CROSBI ID: 30748 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Detection of minimal residual disease in acute promyelocytic leukemia by polymerase chain reaction assay for PML/RARalpha (retinoic acid receptor-alpha) fusion transcript.
Autori
Nemet, Damir ; Grahovac, Blaženka ; Labar, Boris ; Mrsić, Mirando ; Bogdanić, Vinko ; Hitrec, Vlasta ; Zaher, Dunja ; Zadro, Renata ; Boban, Dubravka
Vrsta, podvrsta i kategorija rada
Radovi u zbornicima skupova, cjeloviti rad (in extenso), znanstveni
Izvornik
Molecular Oncology Today
/ Osmak, Maja ; Škrk, Janez - Zagreb : Croatian Ligue Against Cancer, 1996, 149-153
Skup
Molecular Oncology Today
Mjesto i datum
Zagreb, Hrvatska, 19.12.1995
Vrsta sudjelovanja
Pozvano predavanje
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
acute promyelocytic leukemia; PML/RAR alpha; PCR assay; all-trans retinoic acid
Sažetak
Seven patients with acute promyelocytic leukemia (APL)treated with all-trans retinoic acid (ATRA) for remission (CR) induction and with chemotherapy (CT) for consolidation of CR underwent residual disease monitoring through reverse transcription polymerase chain reaction (PCR) for PML/retinoic acid receptor alpha (PML/RAR alpha) fusion transcript. In six patients PCR was positive immediately after ATRA induced CR and/or after the first CT course.Two patients became PCR negative following repeated courses of CT and they are in remission 7 and 14 months, respectively. Four other patients relapsed. This pilot study indicates that PCR for PML/RAR alpha is very sensitive assay for detection of residual disease in APL.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Projekti:
214006
Ustanove:
Klinički bolnički centar Zagreb
Profili:
Boris Labar
(autor)
Blaženka Grahovac
(autor)
Renata Zadro
(autor)
Mirando Mrsić
(autor)
Dubravka Boban
(autor)
Vinko Bogdanić
(autor)
Damir Nemet
(autor)